Obesity Services & Products

  1. Ergomed's Risk-Based Quality Management 2/6/2025

    Ergomed’s Meticulous Risk-Based Quality Management Approach

    As a pioneer in providing comprehensive support for your clinical research, Ergomed champions an innovative Risk-Based Quality Management (RBQM) approach. This forward-thinking strategy ensures the highest patient safety standards, regulatory compliance, and data reliability. Ergomed’s proactive approach to managing clinical trials tackles clinical research complexity head-on.

  2. Targeted Source Data Verification 2/6/2025

    Ergomed’s Risk-Based Clinical Monitoring and Source Data Verification Approach for Data Integrity

    Ergomed ensures the highest data integrity and patient safety standards through our risk-based clinical monitoring and Source Data Verification (SDV) practices. SDV is a critical process in clinical trials that ensures the data collected are accurate, complete, and verifiable against the source documents. We compare data entered into case report forms or electronic data capture systems with the source data to confirm their accuracy and reliability.

  3. Ergomed's Patient-Centric Focus Drives Our Team 2/6/2025

    Ergomed places patients and their care partners’ needs at the core of our services. We strive to build empathetic relationships with patients and their care partners, not just during the trial but also before and after. Our team provides personalized support, aiming to alleviate the burden of study participation. Ergomed and our trusted partners are deeply committed to bringing lifesaving treatments to patients.

  4. Regulatory Consultancy Services 2/6/2025

    Global Strategies to Align Your Goals With Regulatory Requirements

    Ergomed’s regulatory consultancy services are guided by a team of seasoned consultants, each bringing a wealth of experience from regulatory agencies and in-house roles. This expertise ensures a proactive and flexible solution tailored to your project’s unique needs and timelines, instilling confidence in our services.

  5. Reviewing Protocols Across Therapeutic Areas 2/5/2025

    A successful clinical trial starts with an efficient protocol review.

    With deep roots in academic research and clinical medicine, BRANY IRB is uniquely positioned to meet your cost and speed requirements. Get your clinical trial to the start line while ensuring participant health and safety.

  6. Streamline Electronic Data Capture With iMednet EDC 1/22/2025

    At the core of our comprehensive eClinical platform, iMednet EDC is uniquely designed to help sponsors and CROs achieve their clinical research goals. Highly flexible, it enables you to build studies quickly, while easily adapting to complex protocols and mid-study changes with ease.

  7. Get The Right Participants For Your Study Easier And Faster 1/22/2025

    Clinical trial recruitment solution: Get the right participants for your clinical research study easier and faster than ever before.

  8. How iMednet Addresses Key Industry Challenges 1/22/2025

    In today’s complex clinical research landscape, sponsors and CROs face numerous challenges that can impact study timelines, costs, and data quality. The iMednet platform offers innovative solutions to address these critical issues.

  9. How Can You Simplify Disclosure Compliance For Global Clinical Trials? 1/17/2025

    The most widely trusted solution for clinical trial disclosure management

    Managing clinical trial disclosures can be tedious and error-prone, opening the door to noncompliance. TrialScope Disclose provides a better way.

    Our centralized platform automates data entry and reporting for Clinicaltrials.gov, CTIS, and more. This reduces manual effort so you can focus on bringing new treatments to patients, not paperwork.

  10. Proven Expertise With Global Solutions For U.S. Biotechs 1/7/2025

    The success of a biotech drug development program often depends on the relationship it forms with its Clinical Research Organization (CRO) partner.

    Avance Clinical, a global CRO with more than 3 decades of experience, has an impressive track record in the US with over 200 US studies including 140 in oncology.